PMID: 8266221Jun 1, 1993Paper

Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam

The Southeast Asian Journal of Tropical Medicine and Public Health
K Na BangchangT Harinasuta

Abstract

Mefloquine levels were compared between Plasmodium falciparum malaria patients with sensitive response and those with treatment failure who received 3 drug regimens of mefloquine (46 patients with MSP 3 tablets (Fansimef), 38 and 34 with mefloquine (Lariam) 750 mg and 1,250 mg). Mefloquine concentrations on Day-1 in any regimens in patients with treatment failure were significantly lower than those from the sensitive response, whereas there was no difference in the concentrations on Day-7. However, MIC values of mefloquine prior to drug treatment were comparable in both groups. The study suggests that pre-treatment in vitro sensitivity testing was a non-reliable indicator of clinical outcome. Mefloquine concentration on the first day after treatment is a better predictor of the treatment outcome.

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

The Southeast Asian Journal of Tropical Medicine and Public Health
J KarbwangT Harinasuta
The Southeast Asian Journal of Tropical Medicine and Public Health
J KarbwangT Harinasuta
Transactions of the Royal Society of Tropical Medicine and Hygiene
E C ReisingerM Dietrich
The Southeast Asian Journal of Tropical Medicine and Public Health
J KarbwangT Harinasuta
Bulletin de la Société de pathologie exotique et de ses filiales
R Lasserre
© 2021 Meta ULC. All rights reserved